Publication: 2880

Publication: 2880

CODEL: phase III study of RT, RT + TMZ, or TMZ for newly diagnosed 1p/19q codeleted oligodendroglioma. Analysis from the initial study design

PubMed

PMC

QxMD

DOI

Google Scholar

Citation:: Neuro Oncol vol 23 (3) 457-467

Year:: 2020
Type:: Manuscript
Funding:: NCTN
Endpoint:: Primary
Analysis:: Preliminary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: pmc-release

Note:: CODEL (ALLIANCE N0577; EORTC 26081-22086; NRG 1071; NCIC CEC-2

Methodological:: No
Biospecimen:: No
SDC:: No
Book Volume:: 10

Parents:: 2373 2432 3379
Children:: None

Program:: OGC
Primary Committee:: Neuro-Onc
Sec. Committees:

Pharmas:
Grants:: U10CA180821, U10CA180882, UG1CA233320, UG1CA233329, UG1CA232760; U10CA180820 (ECOG-ACRIN); U10CA180863 (CCTG); U10CA180868 (NRG)

Corr. Author:
Authors:: Kurt A Jaeckle Karla V Ballman Martin van den Bent Caterina Giannini Evanthia Galanis Paul D Brown Robert B Jenkins J Gregory Cairncross Wolfgang Wick Michael Weller Kenneth D Aldape Jesse G Dixon S Keith Anderson Jane H Cerhan Jeffrey S Wefel Martin Klein Stuart A Grossman David Schiff Jeffrey J Raizer Frederick Dhermain Donald G Nordstrom Patrick J Flynn Michael A Vogelbaum

Networks:: CA011, FL065, IA085, LAPS-IL036, LAPS-MN026, LAPS-TX035, MN017, MN022, OH027, VA009

Study: NCCTG-N0577
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 3

Keywords:: CODEL, 1p/19q, codeleted, N0577, oligodendroglioma